⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26197583 | 1.00 | — | — | |
| SCHEMBL322454 | 0.80 | — | — | |
| SCHEMBL28263163 | 0.80 | ALDH1A1 (0.53) | — | |
| Urea SCHEMBL28231050 | 0.80 | — | — | |
| SCHEMBL189800 | 0.80 | — | — | |
| SCHEMBL4364106 | 0.80 | — | — | |
| SCHEMBL542866 | 0.80 | — | — | |
| SCHEMBL447922 | 0.77 | — | — | |
| Hydrochloric Acid SCHEMBL5007373 | 0.77 | — | — | |
| SCHEMBL13585547 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114437250-B | Chitosan oligosaccharide amino hydroxy propionamide derivative and preparation method thereof | 内蒙古农业大学 | 2023-07-04 | — | — | CN | claimed |
| CN-114437250-A | Chitosan oligosaccharide amino hydroxyl propionamide derivative and preparation method thereof | 内蒙古农业大学 | 2022-05-06 | — | — | CN | claimed |
| US-8329644-B2 | Lantibiotic-based compounds having antimicrobial activity | NOVACTA BIOSYSTEMS LIMITED (GB) | 2012-12-11 | — | — | US | claimed |
| US-20100261638-A1 | LANTIBIOTIC-BASED COMPOUNDS HAVING ANTIMICROBIAL ACTIVITY | NOVACTA BIOSYSTEMS LIMITED (GB) | 2010-10-14 | — | — | US | claimed |
| EP-2167527-A2 | LANTIBIOTIC-BASED COMPOUNDS HAVING ANTIMICROBIAL ACTIVITY | Novacta Biosystems Limited (GB) | 2010-03-31 | — | — | EP | claimed |
| WO-2009010765-A2 | LANTIBIOTIC-BASED COMPOUNDS HAVING ANTIMICROBIAL ACTIVITY | NOVACTA BIOSYSTEMS LIMITED (GB) | 2009-01-22 | — | — | WO | claimed |
| WO-2023239941-A1 | IMIDAZO(1,2-A)PYRIDINE DERIVATIVES AS RIPK2 INHIBITORS | INTERLINE THERAPEUTICS INC. (US) | 2023-12-14 | — | — | WO | disclosed |
| CN-114437250-B | Chitosan oligosaccharide amino hydroxy propionamide derivative and preparation method thereof | 内蒙古农业大学 | 2023-07-04 | — | — | CN | disclosed |
| CN-114437250-B | Chitosan oligosaccharide amino hydroxy propionamide derivative and preparation method thereof | 内蒙古农业大学 | 2023-07-04 | — | — | CN | disclosed |
| CN-114437250-B | Chitosan oligosaccharide amino hydroxy propionamide derivative and preparation method thereof | 内蒙古农业大学 | 2023-07-04 | — | — | CN | disclosed |
| CN-114437250-A | Chitosan oligosaccharide amino hydroxyl propionamide derivative and preparation method thereof | 内蒙古农业大学 | 2022-05-06 | — | — | CN | disclosed |
| US-20160303243-A1 | ANIONIC CONJUGATES OF GLYCOSYLATED BACTERIAL METABOLITE | GLYCAN BIOSCIENCES LLC (US) | 2016-10-20 | — | — | US | disclosed |
| US-9346845-B2 | Anionic conjugates of glycosylated bacterial metabolite | GLYCAN BIOSCIENCES LLC (US) | 2016-05-24 | — | — | US | disclosed |
| EP-2178552-A1 | THE USE OF TYPE-B LANTIBIOTIC-BASED COMPOUNDS HAVING ANTIMICROBIAL ACTIVITY | Novacta Biosystems Limited (GB) | 2010-04-28 | — | — | EP | disclosed |
| EP-2167527-A2 | LANTIBIOTIC-BASED COMPOUNDS HAVING ANTIMICROBIAL ACTIVITY | Novacta Biosystems Limited (GB) | 2010-03-31 | — | — | EP | disclosed |
| US-20090203583-A1 | Use of Type-B Lantibiotic-Based Compounds having Antimicrobial Activity | NOVACTA BIOSYSTEMS LIMITED (GB) | 2009-08-13 | — | — | US | disclosed |
| WO-2009010763-A1 | THE USE OF TYPE-B LANTIBIOTIC-BASED COMPOUNDS HAVING ANTIMICROBIAL ACTIVITY | NOVACTA BIOSYSTEMS LIMITED (GB) | 2009-01-22 | — | — | WO | disclosed |
| WO-2009010765-A2 | LANTIBIOTIC-BASED COMPOUNDS HAVING ANTIMICROBIAL ACTIVITY | NOVACTA BIOSYSTEMS LIMITED (GB) | 2009-01-22 | — | — | WO | disclosed |
| WO-2008011478-A2 | METHODS FOR TREATING CHRONIC PAIN USING 3-ARYL-3-HYDROXY-2-AMINO-PROPIONIC ACID AMIDES, 3-HETEROARYL-3-HYDROXY-2-AMINO-PROPIONIC ACID AMIDES AND RELATED COMPOUNDS | ALLERGAN, INC. (US) | 2008-01-24 | — | — | WO | disclosed |
| EP-1876168-A1 | Method for manufacturing beta amino alpha hydroxy carboxylic acid amides | Evonik Degussa GmbH (DE) | 2008-01-09 | — | — | EP | disclosed |